Chemotherapy has been a standard part of breast cancer treatment for decades. It has helped countless patients survive the ...
Despite the often-invasive therapies, life after cancer treatment can be just as if not more challenging than the disease ...
A breast cancer diagnosis can turn your world upside down while navigating through treatment, reconstruction, and the ...
Women from across the Triangle gathered Saturday in Durham for the 21st Annual Tea for Two, an event aimed at raising ...
Morning Overview on MSN
A new genomic test could spare two-thirds of high-risk breast cancer patients from chemotherapy entirely, per ASCO 2026 results
Thousands of women diagnosed with high-risk, estrogen-receptor-positive breast cancer may no longer need chemotherapy, ...
A new study found that a structured yoga program helped cancer survivors experience major improvements in sleep, mood, ...
There’s an urgent need for resources that are tailored, well‑funded and culturally competent for Black women. In 2025, the breast cancer mortality rate for Black women remains 40% higher than that of ...
Millions of breast cancer patients could be spared chemotherapy with a revolutionary new genomic test, a clinical trial has ...
MedPage Today on MSN
PAM Inhibitor Doubles Time to Progression in Advanced Breast Cancer Subset
Novel gedatolisib is currently under review at FDA for wild-type patients ...
By Christy Santhosh June 2 (Reuters) - Celcuity shares slumped 25%, set for their biggest one-day decline, on Tuesday after its experimental breast cancer treatment extended the period of time a ...
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...
Women from across the Triangle gathered Saturday in Durham for the 21st Annual Tea for Two, an event aimed at raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results